NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • XYZ.
  • XY.
  • #TrumpTrade
  • Invest ↗
Sign in Subscribe

Engaged Capital Pushes Cognex to Cut Costs, Eyes Stock Price Double

Activist investor Engaged Capital builds major stake in Cognex, pushing for cost cuts and consulting help to potentially double the machine vision company's stock price within two years.

Engaged Capital Pushes Cognex to Cut Costs, Eyes Stock Price Double
Credit: Cognex
Already have an account? Sign in.
10/21/2025 · 2:46 PM
CGNX
/ Read more

Feed↓

Perrigo Rethinks Its Baby Formula Business
11/05/2025 · 11:59 AM

Perrigo Rethinks Its Baby Formula Business

Perrigo reviews its store-brand baby formula business due to quality issues. It is shifting focus to higher-profit health brands instead.

/ Subscriber only
FDA Greenlights Linaclotide (Linzess) for Children 7 Years and Older with Irritable Bowel Syndrome with Constipation
11/05/2025 · 11:40 AM

FDA Greenlights Linaclotide (Linzess) for Children 7 Years and Older with Irritable Bowel Syndrome with Constipation

Ironwood's Linzess is the first FDA-approved drug for children 7+ with IBS-C (chronic constipation, pain, and bloating).

/ Subscriber only
Orexin Drug Race: Centessa Shows Promise, Alkermes Stands Strong
Featured/ 11/05/2025 · 10:28 AM

Orexin Drug Race: Centessa Shows Promise, Alkermes Stands Strong

Centessa has great sleep drug data, easing daytime sleepiness. Alkermes stock jumped 7% as its competing drug is still strong.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe